NCT01152060Unknown不适用
an Open Parallel Clinical Trial in HBV-GN Patients
Nanchang University0 个研究点目标入组 10 人开始时间: 2010年1月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 10
研究概览
简要总结
Lamivudine treatment for HBV-DNA negative HBV-GN patients.
详细描述
lamivudine and predinisone treatment for HBV-DNA negative HBV-GN patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult HBV-GN patients with biopsy-proven MN, heavy protinuria, HBsAg or HBeAg positive, HBV-DNA negative
排除标准
- •Primary MN patients, HBV-DNA positive
研究者
相似试验
已完成
4 期
A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy AdultsHepatitis BNCT02203357Peking University353
撤回
不适用
Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVHIV InfectionsHepatitis BNCT00051090National Institute of Allergy and Infectious Diseases (NIAID)
Unknown
4 期
Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyChronic Hepatitis BNCT01804387Korea University60
撤回
4 期
Telbivudine monotherapy for HIV-HBV coinfected patients: an open explorative study.hepatitis Bjaundice10047438NL-OMON32543niversitair Medisch Centrum Utrecht35
终止
1 期
A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) InfectionChronic Hepatitis BHepatitis B, ChronicHepatitis B InfectionHBVHepatitis BNCT02826018Alnylam Pharmaceuticals24